These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11996025)

  • 1. To what extent can we explain time trade-off values from other information about respondents?
    Dolan P; Roberts J
    Soc Sci Med; 2002 Mar; 54(6):919-29. PubMed ID: 11996025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valuing health status using VAS and TTO: what lies behind the numbers?
    Robinson A; Dolan P; Williams A
    Soc Sci Med; 1997 Oct; 45(8):1289-97. PubMed ID: 9381241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-of-life valuations of advanced breast cancer by New Zealand women.
    Milne RJ; Heaton-Brown KH; Hansen P; Thomas D; Harvey V; Cubitt A
    Pharmacoeconomics; 2006; 24(3):281-92. PubMed ID: 16519549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods.
    Yusof FA; Goh A; Azmi S
    Value Health; 2012; 15(1 Suppl):S85-90. PubMed ID: 22265073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valuations of EQ-5D health states: are the United States and United Kingdom different?
    Johnson JA; Luo N; Shaw JW; Kind P; Coons SJ
    Med Care; 2005 Mar; 43(3):221-8. PubMed ID: 15725978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-state valuations for pertussis: methods for valuing short-term health states.
    Lee GM; Salomon JA; LeBaron CW; Lieu TA
    Health Qual Life Outcomes; 2005 Mar; 3():17. PubMed ID: 15780145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling valuations for health states: the effect of duration.
    Dolan P
    Health Policy; 1996 Dec; 38(3):189-203. PubMed ID: 10162421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?
    Mulhern B; Shah K; Janssen MF; Longworth L; Ibbotson R
    Value Health; 2016; 19(2):210-7. PubMed ID: 27021755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets.
    Tsuchiya A; Brazier J; Roberts J
    J Health Econ; 2006 Mar; 25(2):334-46. PubMed ID: 16271783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of age on health state valuations.
    Dolan P
    J Health Serv Res Policy; 2000 Jan; 5(1):17-21. PubMed ID: 10787582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual differences in the use of the response scale determine valuations of hypothetical health states: an empirical study.
    Essink-Bot ML; Stuifbergen MC; Meerding WJ; Looman CW; Bonsel GJ;
    BMC Health Serv Res; 2007 Apr; 7():62. PubMed ID: 17466068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How dead is dead? Qualitative findings from participants of combined traditional and lead-time time trade-off valuations.
    Al Sayah F; Mladenovic A; Gaebel K; Xie F; Johnson JA
    Qual Life Res; 2016 Jan; 25(1):35-43. PubMed ID: 26216584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L.
    Ramos-Goñi JM; Rand-Hendriksen K; Pinto-Prades JL
    Value Health; 2016 Jun; 19(4):478-86. PubMed ID: 27325340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inconsistencies in TTO and VAS values for EQ-5D health states.
    Lamers LM; Stalmeier PF; Krabbe PF; Busschbach JJ
    Med Decis Making; 2006; 26(2):173-81. PubMed ID: 16525171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valuation of EQ-5D health states in Poland: first TTO-based social value set in Central and Eastern Europe.
    Golicki D; Jakubczyk M; Niewada M; Wrona W; Busschbach JJ
    Value Health; 2010; 13(2):289-97. PubMed ID: 19744296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
    Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
    Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconsidering the use of rankings in the valuation of health states: a model for estimating cardinal values from ordinal data.
    Salomon JA
    Popul Health Metr; 2003 Dec; 1(1):12. PubMed ID: 14687419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies.
    Shah K; Mulhern B; Longworth L; Janssen MF
    Value Health; 2016 Jan; 19(1):53-9. PubMed ID: 26797236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the EQ-5D reflect lost earnings?
    Tilling C; Krol M; Tsuchiya A; Brazier J; Exel Jv; Brouwer W
    Pharmacoeconomics; 2012 Jan; 30(1):47-61. PubMed ID: 22066754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.